In a study comprising a large cohort of neuroblastoma cases registered with the Children’s Oncology Group study, 11q LOH and 1p LOH or MYCN amplification were independent poor prognostic markers as determined by multivariable analysis (6). Here, MYCN is linked to neuroblastoma.